Beijing Qingke Biotechnology
A gene synthesis platform enterprise with an independent whole industry chain.
Launch date
Employees
Market cap
-
Enterprise valuation
$220—330m (Dealroom.co estimates Dec 2022.)
Beijing China (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
* | CNY400m | Series B | |
Total Funding | $55.0m |